PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Kirby I Bland Selected Research
Estrogens (Estrogen)
10/2008
Mechanism of estrogen-mediated improvement in cardiac function after trauma-hemorrhage: p38-dependent normalization of cardiac Akt phosphorylation and glycogen levels.
08/2008
Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G.
07/2008
The role of estrogen receptor subtypes on hepatic neutrophil accumulation following trauma-hemorrhage: Direct modulation of CINC-1 production by Kupffer cells.
06/2008
Mechanism of estrogen-mediated intestinal protection following trauma-hemorrhage: p38 MAPK-dependent upregulation of HO-1.
04/2008
Mitogen activated protein kinase (MAPK) mediates non-genomic pathway of estrogen on T cell cytokine production following trauma-hemorrhage.
03/2008
Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following trauma-hemorrhage.
03/2008
Estrogen: a novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations.
10/2007
Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-dependent HO-1 up-regulation.
09/2007
Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of the PI-3K/Akt pathway.
06/2007
Role of p38 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage.
06/2007
The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage.
06/2007
The role of estrogen receptor subtypes in ameliorating hepatic injury following trauma-hemorrhage.
05/2007
Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage.
05/2007
Downregulation of TLR4-dependent ATP production is critical for estrogen-mediated immunoprotection in Kupffer cells following trauma-hemorrhage.
02/2007
Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway.
01/2006
Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1.
12/2005
PGC-1 upregulation via estrogen receptors: a common mechanism of salutary effects of estrogen and flutamide on heart function after trauma-hemorrhage.
05/2002
Estrogen pretreatment protects males against hypoxia-induced immune depression.
Articles by Research Topic
Disease
64
Wounds and Injuries (Trauma)
10/2008 - 01/2002
57
Hemorrhage
10/2008 - 01/2002
7
Sepsis (Septicemia)
09/2007 - 01/2002
6
Hemorrhagic Shock
01/2006 - 06/2003
5
Neoplasms (Cancer)
06/2006 - 05/2003
3
Breast Neoplasms (Breast Cancer)
05/2003 - 04/2002
2
Bone Fractures (Bone Fracture)
01/2007 - 01/2007
2
Anoxia (Hypoxia)
09/2006 - 05/2002
2
Colorectal Neoplasms (Colorectal Cancer)
06/2005 - 11/2002
2
Burns
05/2005 - 02/2005
1
Hyperparathyroidism
06/2008
1
Vitamin D Deficiency
06/2008
1
Pancreatic Neoplasms (Pancreatic Cancer)
04/2008
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
02/2006
1
Shock
01/2006
1
Edema
05/2005
1
Carcinoma (Carcinomatosis)
05/2003
1
Cholangiocarcinoma
06/2002
Drug/Important Bio-Agent (IBA)
18
Estrogens (Estrogen)
FDA Link
10/2008 - 05/2002
8
Estradiol (Estrace)
FDA Link
Generic
06/2008 - 01/2002
6
Androstenediol
IBA
08/2006 - 08/2004
5
Flutamide (Eulexin)
FDA Link
Generic
08/2008 - 07/2005
5
Interleukin-6 (Interleukin 6)
IBA
03/2007 - 08/2004
4
p38 Mitogen-Activated Protein Kinases
IBA
06/2008 - 09/2006
3
Protein Kinases (Protein Kinase)
IBA
04/2008 - 06/2007
3
Estrogen Receptor alpha
IBA
01/2008 - 08/2006
3
Gonadal Steroid Hormones (Sex Hormones)
IBA
09/2007 - 01/2002
3
Peroxidase (Myeloperoxidase)
IBA
09/2007 - 05/2005
3
Endothelin-1 (Endothelin 1)
IBA
01/2007 - 09/2004
3
Estrogen Receptor beta
IBA
09/2006 - 01/2006
3
Estrogen Receptors
IBA
12/2005 - 03/2003
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
03/2006 - 01/2006
2
Heme Oxygenase (Decyclizing) (Heme Oxygenase)
IBA
07/2005 - 12/2003
2
Prolactin Receptors (Prolactin Receptor)
IBA
12/2003 - 05/2002
2
UAB 30
IBA
11/2003 - 08/2003
2
Tamoxifen
FDA Link
Generic
11/2003 - 06/2002
2
Progesterone
FDA Link
Generic
07/2003 - 06/2003
1
Glycogen
IBA
10/2008
1
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
08/2008
1
Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)
IBA
08/2008
1
Mitogen-Activated Protein Kinases
IBA
07/2007
1
Adenosine Triphosphate (ATP)
IBA
05/2007
1
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
03/2007
1
Keratins (Keratin)
IBA
01/2007
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
01/2007
1
Lidocaine (Xylocaine)
FDA Link
Generic
11/2006
1
src-Family Kinases
IBA
09/2006
1
Heme Oxygenase-1
IBA
09/2006
1
PPAR gamma
IBA
07/2006
1
Biological Markers (Surrogate Marker)
IBA
06/2006
1
Retinoids
IBA
06/2006
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
02/2006
1
Peroxisome Proliferators
IBA
08/2005
1
celecoxib (Celebrex)
FDA Link
06/2005
1
Prolactin
IBA
05/2005
1
Interleukin-18 (Interleukin 18)
IBA
05/2005
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
02/2005
1
Oxygen
IBA
02/2005
1
Steroids
IBA
11/2004
1
Interleukin-10 (Interleukin 10)
IBA
06/2004
1
Methylnitrosourea (N-Methyl-N-nitrosourea)
IBA
11/2003
1
Dehydroepiandrosterone (DHEA)
IBA
08/2003
1
cetuximab (Erbitux)
FDA Link
05/2003
1
Proteins (Proteins, Gene)
IBA
11/2002
1
Nucleic Acids
IBA
11/2002
1
NF-kappa B (NF-kB)
IBA
10/2002
1
Interferon-gamma (Interferon, gamma)
IBA
06/2002
Therapy/Procedure
2
Resuscitation
10/2008 - 06/2003
2
Mastectomy (Mammectomy)
05/2003 - 06/2002
1
Gastric Bypass (Roux-en-Y Gastric Bypass)
06/2008
1
Heterologous Transplantation (Xenotransplantation)
04/2008
1
Mammaplasty (Breast Reconstruction)
06/2002
1
Drug Therapy (Chemotherapy)
04/2002